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Study design
This was a community-based prospective cohort study, carried out in the framework of a county health department. The duration of the follow-up does not appear to have been reported. Individuals interviewed and named in DIS case interviews were arranged into preliminary source-spread tree diagrams showing the relationships among epidemiologically-linked cases, contacts, suspects, and associates. Regarding loss to follow-up, complete data necessary for source-spread analysis were not available for 40 (15.6%) of the 256 direct yield cases. These cases were assumed to have indirect yields similar to the fully characterised cases tested through the same type of test site. Data on motivation for testing were extrapolated to the entire study sample based on a prospective analysis of patient-stated reasons for testing in a cohort comprising 10,594 (30%) of the 35,314 individuals tested. This cohort was comparable with the total tested population in gender, race/ethnicity, age distribution, type of site where tested, and seropositivity.
Analysis of effectiveness
The clinical outcome measures were direct and indirect yield per 1,000 individuals tested. Direct yield cases were defined as individuals with early syphilis who were diagnosed as a result of testing at a study site and self-motivated (i.e., not named by another individual who could have been the source of infection). Other cases, contacts, suspects, and associates who were epidemiologically linked to a direct yield case were defined as indirect yield. Other outcomes reported were the numbers of contacts and clusters named, not located, not infected, and epidemiologic treatment given.
Effectiveness results
The direct yield results per 1,000 individuals tested were as follows: The number of contacts and clusters named was 13.19 in all sites, 21.36 in the STD clinic, and 7.66 in other sites.
The number of contacts and clusters named but not located was 6.23 in all sites, 10.64 in the STD clinic, and 3.19 in other sites. 
Clinical conclusions
It appears that, compared to testing, the contribution of field epidemiology to case-finding is relatively small, and that the cases found through this method may not be uniquely important to transmission of disease in the community.
Measure of benefits used in the economic analysis
The measure of benefits used were the number of new (i.e., previously undiagnosed) early syphilis cases detected and the number of CDC's Weighted Disease Intervention Index points (which recognises and quantifies multiple outcomes of epidemiologic activity). The CDC Index considers cases found, epidemiologic treatments given, and clusters to primary and secondary cases brought to evaluation and treatment. The equation and weighting system were presented in the paper.
Direct costs
Costs were not discounted due to the short time frame of the cost analysis. Some resource use quantities were reported separately from the costs. Cost items were reported separately. Cost analysis covered the costs of testing (personnel and materials) and partner notification (DIS activities including original interview, locating named contacts, interviewing located contacts, and case follow-up, including re-interviews). The perspective adopted in the cost analysis does not appear to have been explicitly specified. A time-motion study of DIS activity in managing 49 cases was employed to estimate the amount of DIS time spent on each of the DIS activities using a standardised form recorded by the DIS staff. The personnel input into testing was determined by using a restricted time study in the county clinic and laboratory. Data from the STD clinic were used to estimate costs at all clinics. The costs of the materials were based on the actual purchase costs that incorporated volume discounts. The authors reported that, because of the difficulties inherent in using true marginal costs in this type of study, average costs of testing and partner notification were calculated, and were used as a proxy for marginal costs. This methodology assumed that a partner notification programme existed to carry out epidemiologic management for STDs other than syphilis. The price year was not specified.
Indirect Costs
Not included.
Currency

US dollars ($).
Sensitivity analysis
Not conducted.
Estimated benefits used in the economic analysis
Direct yield cases were discovered at a rate of 7.5 cases per 1,000 individuals tested. The rate in the STD clinic was 12/1,000, and that of other sites was 4.3/1,000.
All generations of epidemiologic management activities, identified an additional 1.3 previously undiagnosed cases per 1,000 individuals tested. The corresponding values for the STD clinic were 2.16 and other sites, 0.97.
The values calculated for the number of CDC's Weighted Disease Intervention Index points appear not to have been reported (although they can be computed based on the data provided in the paper).
data were used; the effects of alternative procedures on indirect costs were not addressed; statistical analyses were not performed on resource use and cost data. The cost results may not be generalisable outside the study settings.
Other issues
The authors' conclusions appear to be justified given the uncertainties in the data. Regarding the issue of generalisability to other settings or countries, it was acknowledged that the results of this analysis may not be generalisable to other communities due to sensitivity analysis not having been performed. The issue of whether the study sample was representative of the study population was not discussed. An incremental cost-effectiveness ratio could be calculated by using an appropriate comparator (not using any case-finding method, for example).
Implications of the study
The study results suggest that large-scale testing should be restricted to sites where the prevalence of infection makes testing cost-effective. It is important for STD programmes to examine their own local data when making programme design decisions. The results of this study should also prompt a wider re-evaluation of syphilis control activities.
Coupled with the results of other research in the authors' community, this study suggests that testing combined with field epidemiology does not exert positive effects deeply into the affected population. This situation calls for more research to clarify the effectiveness of intervention techniques. It also demands consideration of alternate interventions (e.g., primary prevention, selective mass treatment, and more effective field methods for reaching "core" transmitters) to achieve more effectively the personal and public health goals of syphilis control programmes.
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